Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients

Archives of Dermatological Research

Volumn 305, Issue 3, 2013, Pages 191-195

  Narbutt, Joanna ^a   Olejniczak, Irmina ^a   Sobolewska Sztychny, Dorota ^a   Sysa Jedrzejowska, Anna ^a   Słowik Kwiatkowska, Iwona ^b   Hawro, Tomasz ^a   Lesiak, Aleksandra ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b University of Lublin   (Poland)

Author keywords

IL 31; Narrow band UVB; Neuropeptides; Psoriasis vulgaris

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALCITONIN GENE RELATED PEPTIDE; CORTICOTROPIN RELEASING FACTOR; INTERLEUKIN 31; SUBSTANCE P;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; NARROW BAND ULTRAVIOLET B RADIATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PRURITUS; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; RADIATION EXPOSURE; SCORING SYSTEM; ULTRAVIOLET B RADIATION;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CALCITONIN GENE-RELATED PEPTIDE; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; PRURITUS; PSORIASIS; QUESTIONNAIRES; SKIN; SUBSTANCE P; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY;

EID: 84876482018     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-012-1293-6     Document Type: Article

References (29)

1. Aydogan K, Karadogan SK, Tunali S, Adim SB, Ozcelik T (2006) Narrowband UVB phototherapy for small plaque parapsoriasis. J Eur Acad Dermatol Venereol 20:573-577
2. Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M, Yao L, Storey H, LeCiel C, Harder B, Gross JA (2006) IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 117:418-425
3. Chang SE, Han SS, Jung HJ, Choi JH (2007) Neuropeptides and their receptors in psoriatic skin in relation to pruritus. Br J Dermatol 156:1272-1277
4. Chapman BP, Moynihan J (2009) The brain-skin connection: role of psychosocial factors and neuropeptides in psoriasis. Expert Rev Clin Immunol 5:623-627
5. Chrousos GP, Gold PW (1992) The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267:1244-1252
6. Darsow U, Ring J (2001) Neuroimmune interactions in the skin. Curr Opin Allergy Clin Immunol 1:435-439
7. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J, Bort S, Mudri S, Kuijper JL, Bukowski T, Shea P, Dong DL, Dasovich M, Grant FJ, Lockwood L, Levin SD, LeCiel C, Waggie K, Day H, Topouzis S, Kramer J, Kuestner R, Chen Z, Foster D, Parrish-Novak J, Gross JA (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5:752-760
8. Farber EM, Nickoloff BJ, Recht B, Fraki JE (1986) Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 14:305-311
9. Halevy S, Livni E (1993) Beta-adrenergic blocking drugs and psoriasis: the role of an immunologic mechanism. J Am Acad Dermatol 29:504-505
10. Kim JE, Cho DH, Kim H, Kim HJ, Lee JY, Cho BK, Park HJ (2007) Expression of the corticotropin-releasing hormone-proopiomelanocortin axis in the various clinical types of psoriasis. Exp Dermatol 16:104-109
11. Lesiak A, Narbutt J, Pawlaczyk M, Sysa-Jedrzejowska A, KrzyÅcin J (2011) Vitamin D serum level changes in psoriatic patients treated with narrowband ultraviolet B phototherapy are related to the season of the irradiation. Photodermatol Photoimmunol Photomed 27:304-310
12. Nakamura M, Toyoda M, Morohashi M (2003) Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol 149:718-730
13. O'Kane M, Murphy EP, Kirby B (2006) The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease. Exp Dermatol 15:143-153
14. Parrish JA, Jaenicke KF (1981) Action spectrum for phototherapy of psoriasis. J Invest Dermatol 76:359-362
15. Raap U, Goltz C, Deneka N, Bruder M, Renz H, Kapp A, Wedi B (2005) Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. J Allergy Clin Immunol 115:1268-1275
16. Raap U, Werfel T, Goltz C, Deneka N, Langer K, Bruder M, Kapp A, Schmid-Ott G, Wedi B (2006) Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis. Allergy 61:1416-1418
17. Raychaudhuri SP, Farber EM (2000) Neuroimmunologic aspects of psoriasis. Cutis 66:357-362
18. Reich A, Orda A, WiÅicka B, Szepietowski JC (2007) Plasma neuropeptides and perception of pruritus in psoriasis. Acta Derm Venereol 87:299-304
19. Reich A, Szepietowski JC (2007) Mediators of pruritus in psoriasis. Mediators Inflamm 2007:64727
20. Saraceno R, Kleyn CE, Terenghi G, Griffiths CE (2006) The role of neuropeptides in psoriasis. Br J Dermatol 155:876-882
21. Scholzen TE, Luger TA (2004) Neutral endopeptidase and angiotensin-converting enzyme - key enzymes terminating the action of neuroendocrine mediators. Exp Dermatol 13:22-26
22. Sonkoly E, Muller A, Lauerma I, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B (2006) IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117:411-417
23. Szepietowski JC, Reich A, WiÅnicka B (2002) Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat 10:221-226
24. Szepietowski JC, Reich A, WiÅnicka B (2004) Pruritus and psoriasis. Br J Dermatol 151:1284
25. Tagen M, Stiles L, Kalogeromitros D, Gregoriou S, Kempuraj D, Makris M, Donelan J, Vasiadi M, Staurianeas NG, Theoharides TC (2007) Skin corticotropin-releasing hormone receptor expression in psoriasis. J Invest Dermatol 127:1789-1791
26. Tsigos C, Chrousos GP (2002) Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53:865-871
27. Weigl BA (2000) The significance of stress hormones (glucocorticoids, catecholamines) for eruptions and spontaneous remission phases in psoriasis. Int J Dermatol 39:678-688
28. Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL (2000) The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 143:969-973
29. Zhou C, Yu X, Cai D, Liu C, Li C (2009) Role of corticotropin-releasing hormone and receptor in the pathogenesis of psoriasis. Med Hypotheses 73:513-515